Navigation Links
Royal Arch Masons present Autism Speaks with $100,000 Royal Arch research assistance grant
Date:11/16/2011

NEW YORK, N.Y. (November 16, 2011) -- The General Chapter of Royal Arch Masons International presented Autism Speaks, the world's largest autism research and advocacy organization, with a $100,000 Royal Arch Research Assistance (RARA) grant in support of the Autism Speaks early diagnosis and early intervention initiative to investigate auditory processing disorders in children with autism.

Many of the precursor symptoms of auditory processing disorders are seen in some children with Autism Spectrum Disorder (ASD). These symptoms include trouble paying attention and remembering information; poor listening skills; difficulty in processing information; behavioral problems; difficulty with comprehending language; and anxiety or confusion in social situations. Young children on the autism spectrum who exhibit precursor symptoms may be diagnosed with a central auditory processing disorder (CAPD) at a later age.

The RARA grant will enable Autism Speaks to address precursor symptoms of auditory processing disorders in an effort to create better outcomes for children who are at risk for developing both ASD and CAPD. In addition, the grant will go towards funding Autism Speaks' efforts to educate healthcare providers and parents about the role of auditory processing disorders in a child's autism diagnosis as well as encourage further evaluation for young children who demonstrate auditory processing difficulty

"Children who show early signs of autism spectrum disorders are at risk for a number of developmental problems," noted Dr. Geri Dawson, chief science officer of Autism Speaks. "With the help of this grant, clinicians can better understand the early signs of auditory processing disorder in children with autism, allowing for treatment of this disorder to begin as early as possible."

Autism Speaks will also disseminate and share information developed in this effort with caregivers and clinicians including methods to treat auditory processing problems associated with ASD.

"The Royal Arch Masons have been supporting central auditory processing disorder research for over 30 years through the Royal Arch Research Assistance grants and we are delighted to partner with Autism Speaks in this venture," said Royal Arch Mason General Grand High Priest, Most Excellent Edmund D. Harrison. "The Royal Arch Mason's forward look forward to participating in events around the country sponsored by Autism Speaks and assisting in their fundraising efforts to assist families affecting by autism."

The grant will build on the work of Autism Speaks Toddler Treatment Network, a consortium of eight research sites established in 2006 to determine the efficacy of intervention earlier than 18 months of age. Its focus is on clinical research to establish best practices and actively train clinicians and caregivers in treatment techniques appropriate for toddlers. The primary beneficiaries of the Toddler Treatment Network are young children under age three with ASD or at risk for developing ASD, as well as their parents and primary caregivers.


'/>"/>

Contact: Jane E. Rubinstein
jrubinstein@rubenstein.com
212-843-8287
Autism Speaks
Source:Eurekalert  

Related medicine news :

1. Swedes think highly of the government -- but not of the royal family
2. Unilens Vision Reports Record Second Quarter Earnings And Royalty Income
3. Plotting and treachery in ant royal families
4. Horst Sievert, M.D., Ph.D. presented with Master Clinical Operator Award at TCT 2011
5. NYU Langone experts present at Society for Neuroscience Annual Meeting
6. Results of the PARTNER Trial Cohort B 2-year follow up presented at TCT 2011
7. Society for Integrative Oncology releases findings presented at annual meeting
8. Eric J. Topol, M.D. presented with 2011 TCT Career Achievement Award
9. Study shows why underrepresented men should be included in binge eating research
10. BU presents approach to access biorelevant structures by remodeling natural products
11. Cedars-Sinai scientists, physicians to be key presenters at World Stem Cell Summit
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Royal Arch Masons present Autism Speaks with $100,000 Royal Arch research assistance grant
(Date:5/6/2016)... ... ... Logically, spring weather, with its moderate humidity and temperatures, should be ideal ... hot, water on the eye surface can evaporate, creating uncomfortable dry eye symptoms. In ... one problem, according to radio show and water advocate Sharon Kleyne: Spring is also ...
(Date:5/6/2016)... ... 06, 2016 , ... From the Speaker Podium to the Exhibit Floor at ... insights on managing Customers Engagement at SpeechTek 2016 Event, taking place May 23-25 at ... a Presentation on “5 Customer Engagement Strategies to improve Customer Satisfaction in ...
(Date:5/6/2016)... , ... May 06, 2016 , ... ... to Sleepopolis.com . , Since launching in September, 2014 Sleepopolis has resided ... testing areas, which now include pillows, sheets, mattress toppers, bed frames, and more. ...
(Date:5/6/2016)... , ... May 06, 2016 , ... ... arrival of Sovaldi, which made headlines mostly for its cost despite its potential ... and moral questions surrounding the drug—part of a class called direct-acting antivirals (DAAs)—have ...
(Date:5/6/2016)... ... May 06, 2016 , ... Kenneth Cochran, DSc, RN, FACHE, ... of the South announced today that Dr. Robert Menuet, Interventional Cardiologist with Cardiovascular ... Ultrasound Guided Coronary Atherectomy. , This procedure involves the removal of ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... , May 4, 2016  It,s time for an upgrade. There are many medical ... brilliant 3.5 inch LCD, the illustrious DVMAXX HD  offers unparalleled connectivity and functionality.  ... as a world class manufacturer of innovative technology.  Photo - http://photos.prnewswire.com/prnh/20160503/363416 ... ... ...
(Date:5/4/2016)... JERUSALEM , May 4, 2016 ... University of Jerusalem announced today that it had ... BioTheryX, Inc. , developer of novel protein degradation ... the development and commercialization of drug candidates representing first-in-class ... the license were not disclosed. The novel ...
(Date:5/4/2016)... DUBLIN , May 4, 2016 /PRNewswire/ ... the addition of the  "Global Multiple Myeloma ...  report to their offering.       ... Multiple Myeloma Market and Competitive Landscape Highlights ... pipeline products, Multiple Myeloma epidemiology, Multiple Myeloma ...
Breaking Medicine Technology: